Antimicrobial and toxic potential of aqueous extracts of Allium sativum, Hibiscus sabdariffa and Zingiber officinale in Wistar rats  by Sulaiman, Faoziyat A. et al.
Ai
o
o
r
c
t
©
K
1
m
n
p
o
a
P
1
E
hJournal of Taibah University for Science 8 (2014) 315–322
Available  online  at  www.sciencedirect.com
Antimicrobial and toxic potential of aqueous extracts of Allium
sativum, Hibiscus sabdariffa and Zingiber ofﬁcinale in Wistar rats
Faoziyat A. Sulaiman a, Muinat O. Kazeem b, Ahmed M. Waheed a,
Simisade O. Temowo a, Idris O. Azeez a, Faridat I. Zubair a,
Temitope A. Adeyemi b, Azido Nyang b, Oluyomi S. Adeyemi c,∗
a Department of Biochemistry, Faculty of Life Sciences, University of Ilorin, Ilorin, Nigeria
b Department of Microbiology, Faculty of Life Sciences, University of Ilorin, Ilorin, Nigeria
c Department of Biological Sciences, College of Sciences and Engineering, Landmark University, Omu-Aran, Kwara, Nigeria
Available online 4 June 2014
bstract
Allium  sativum,  Hibiscus  sabdariffa  and Zingiber  ofﬁcinale  are medicinal plants with wide use in traditional medicine; however, the
ncreasing use of crude extracts for traditional medicine applications raises safety concerns. We made a preliminary determination
f the phytochemical constituents and antimicrobial and safety profiles of aqueous extracts of A.  sativum,  H.  sabdariffa  and Z.
fﬁcinale. The extracts were administered orally to Wistar rats for 30 days: a control group received distilled water, three groups
eceived the three extract, and a fifth group received a combination of the three extracts. All three extracts, either individually or in
ombination, had antimicrobial activity, and all extracts influenced the activities of marker enzymes. The evidence lends credence
o use of these plants in traditional medicine but also suggests the probable toxic potential of crude plant extracts.
 2014 Taibah University. Production and hosting by Elsevier B.V. All rights reserved.
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.  Introduction
Plant-derived compounds are being used more and
ore widely for their potential chemotherapeutic and
utritional value [1,2]. Administration of medicinal
lants by traditional practitioners remains the mainstay
f some health care systems, especially in the rural
reas of developing countries [3,4]. The World Health∗ Corresponding author. Tel.: +234 8077078099.
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Organization reported [5] that 74% of 119 plant-derived
pharmaceutical remedies are used in modern medicine
in ways that correlate directly with their traditional uses
as medicinal plants, and major pharmaceutical compa-
nies are undertaking extensive research to determine
the medicinal value of plant materials [5]. Medicinal
herbs, vegetables [6,7] and spices contain chemical con-
stituents such as tannins, alkaloids and terpenes, and
their secondary metabolites are a potential source of
novel compounds with various health-promoting effects
[3,8,9].
Plant extracts are commonly used to treat infections
in traditional African medicine, and numerous plants
and herbs are used in Nigeria [10]. Traditional medicine
practices vary from one country to another [11], and
herbal formulations may include extracts from the root,
bark or leaves of various plants [12]. The various appli-
cations of these herbs in traditional medicine system
[10] underscore the need for scientific investigations to
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affirm or disprove the claims of traditional healers. The
increasing consumption of crude extracts of medicinal
plants is becoming a major concern because of safety
issues. Many people believe that, as plants are natu-
ral, they can be consumed safely; unfortunately, this has
proven otherwise [4], and growing concern about the
safety of consuming crude extracts of medicinal plants
was a motivation for this study [3]. We studied aqueous
extracts of Allium  sativum, Hibiscus  sabdariffa  and Zin-
giber ofﬁcinale  for antimicrobial activity in  vitro  and for
biochemical indices in rats in  vivo.
A.  sativum, commonly known as garlic, belongs to
the Alliaceae family, which also includes leek, onion
and shallot. Garlic is used widely in food and medicine
[3,13–16], like other herbs and spices [17]. Use of A.
sativum in alternative medicine has increased over the
years [18–20]. Garlic can be prepared in various forms,
namely oil, powder, raw juice and extracts [21–23]. The
therapeutic effect of garlic has been attributed to its
organosulfur constituents, which also are responsible for
its typical flavour and odour [1,17,24]. Other studies
have implicated thiosulfinates in the antibiotic activity
of garlic [22,25–28].
H.  sabdariffa, hibiscus, is a variety of true roselle,
belonging to the Malvaceae family. The plant is an erect,
sparsely branched annual 4.8 m in height, which is cul-
tivated for its jute-like fibre in India, the East Indies,
Nigeria and to some extent in other parts of tropical
Africa. The stems of this variety are green or red, and the
leaves are green, sometimes with red veins. Its flowers
are yellow, and the red or green, non-fleshy, spiny calyxes
can be used for food [29,30]. Hibiscus tea is consumed
both hot and cold by people around the world [31] as
an infusion made from the crimson or deep magenta-
coloured calyxes of the H.  sabdariffa  flower [32]. It has
a tart, cranberry-like flavour, and sugar is often added to
sweeten the beverage. The tea has been shown to con-
tain vitamin C and minerals and is traditionally used as a
mild medicine. In west Sudan, white hibiscus flowers are
favoured for their bitter taste and are not sold but used
by the owner’s family and guests [31,33].
Z. ofﬁcinale  is a rhizome commonly known as ginger
or ginger root. It can be consumed as a delicacy, medicine
or spice. It lends its name to its genus and family (Zingib-
eraceae). Other notable members of this plant family are
turmeric, cardamom and galangal [34–36]. Ginger culti-
vation began in South Asia and then spread to East Africa
and the Caribbean. Historically, the traditional medical
form of ginger was called Jamaica ginger, which was
classified as a stimulant and carminative [37]. Ginger
has also frequently been used to disguise the taste of
medicines [3]. Studies indicate that ginger may provideersity for Science 8 (2014) 315–322
short-term relief of pregnancy-related nausea and vomi-
ting [34–36].
2.  Materials  and  methods
All reagents were of analytical grade and prepared
with distilled water, unless otherwise stated.
2.1.  Plant  materials
A.  sativum, H.  sabdariffa  and Z.  ofﬁcinale  were pur-
chased on a commercial market, Oja-Oba, in Ilorin,
Kwara State, Nigeria. The plant materials were iden-
tified and authenticated at the herbarium of the Botany
Department, University of Ilorin, Ilorin, Nigeria, where
specimen vouchers have been deposited.
2.2.  Test  organisms
Test organisms were obtained from the culture col-
lection centre of the Microbiology and Parasitology
laboratory of the University of Ilorin Teaching Hospital,
Ilorin, Nigeria. They were isolated from sputum sam-
ples submitted by patients with suspected respiratory
tract infections. The isolates were further subjected to
Gram staining and other biochemical tests according to
standard procedures and were identified as Escherichia
coli, Klebsiella  pneumonia,  Staphylococcus  aureaus  and
Pseudomonas  aeruginosa.
2.3.  Experimental  animals
Wistar rats of an average weight of 180 g were
obtained from the small animal unit of the Department of
Biochemistry, University of Ilorin, Ilorin, Nigeria. They
were housed in a well-ventilated, hygienic environment
and allowed free access to feed (rat pellet purchased from
Bendel Feeds, Ewu, Nigeria) and clean water. The ani-
mals were acclimatized for 2 weeks before the start of
the experiment. Handling was consistent with the ethi-
cal guidelines approved by the University of Ilorin Ethics
Committee for scientific and medical research.
2.4.  Preparation  of  plant  extracts
Fresh samples were cut into pieces with a sterile knife
and dried at room temperature until a constant weight
was obtained. The dried sample was ground to powder,
and 85 g of each sample were percolated in 850 ml dis-
tilled water and allowed to stand for 72 h. The extracts
were then filtered through Whatman no. 1 filter paper,
and the filtrate was vacuum-dried at the Nigerian Stored
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Table 1
Phytochemical analysis of extracts of Allium sativum, Hibiscus sab-
dariffa and Zingiber ofﬁcinale.
Phytochemical A. sativum H. sabdariffa Z. ofﬁcinale
Saponins + + +
Phlobatanins – + –
Terpenoids – + –
Anthraquinones – + –
Flavonoids + – +
Tannins – + –
Glycosides + – –
Steroids – + –
Alkaloids + – −F.A. Sulaiman et al. / Journal of Taib
roduct Research Institute, Ilorin, Nigeria. The extracts
ere stored at 4 ◦C until further use. The yields of the
xtracts were 30% for H.  sabdariffa, 20% for A.  sativum
nd 15% for Z.  ofﬁcinale.
.5.  Phytochemical  screening
Phytochemical tests were carried out on the extracts to
dentify the constituents by standard procedures [38–42].
.6.  Antibacterial  susceptibility
Antibacterial activity was tested by the agar well dif-
usion method. Sterile Mueller–Hinton agar was poured
nto sterile Petri dishes at 45 ◦C and allowed to solidify;
hen, 1 ml of each organism adjusted to 0.5 MacFarland
tandard were swabbed onto the agar with a sterile cot-
on swab. Four wells (5 mm in diameter) were bored into
he agar with a sterile cork borer, and 0.25 ml of recon-
tituted extract was pipetted into the well; streptomycin
nd distilled water served as positive and negative con-
rols. The plates were held for 2 h at room temperature
or diffusion of extracts into the agar and then incubated
t 37 ◦C for 18 h. The diameters of the zones of inhibition
ere then measured. Each experiment was conducted in
uplicate, and the mean values were taken.
.7.  Animal  treatment
The rats were randomized into five groups of three.
ne group served as the control and received distilled
ater; three groups received 10 mg/kg of extract of A.
ativum, H.  sabdariffa  or Z.  ofﬁcinale, and a final group
eceived 10 mg/kg of all three extracts. All extracts were
dministered orally for 30 days. Rats were weighed
eekly.
.8.  Necroscopy
After cessation of treatment, the rats were sacrificed
nder slight diethylether anaesthesia, and blood was col-
ected into a clean centrifuge tube and spun (Heraeus
abofuge 300, Thermo Scientific, Hampshire, United
ingdom) at 4000 ×  g for 10 min to obtain serum. Tis-
ues of interest (liver, kidneys and heart) were harvested,
eighed and homogenized with a Teflon homogenizerSigma–Aldrich Chemie GmbH, Munich, Germany) in
 cold 0.25 mol/L sucrose solution (1:5, w/v). The tis-
ue homogenates were then centrifuged at 5000 ×  g  for
0 min to remove unbroken particulate.Phenolics – + –
2.9.  Biochemical  assays
Alanine transaminase (ALT), aspartate transaminase
(AST) and alkaline phosphatase (ALP) activities were
assayed with Randox assay kits [43–45] in a spectropho-
tometer (Spectrumlab model 752s).
2.10.  Data  analysis
Data are presented as group means ±  SEM (n = 3).
Significant differences among group mean values were
evaluated by one-way analysis of variance. Post-test
analyses were conducted with the Dunnett multiple com-
parison test at 99.5% significance level (α  = 0.05).
3.  Results
The phytoconstituents of the three extracts are pre-
sented in Table 1. Saponins were present in all the
extracts. Phlobatanins, terpenoids, anthraquinones, tan-
nins, steroids and phenolics were detected in extracts of
H. sabdariffa, and flavonoids were found in extracts of
both A.  sativum  and Z.  ofﬁcinale.  Glycosides and alka-
loids were found only in A.  sativum  extracts.
The aqueous extract of Z. ofﬁcinale  was active against
P. aerugenosa  and S. aureus, with highest activity
against the former at a concentration of 200 g (Table 2).
The A.  sativum  extracts showed no inhibitory activity,
while H. sabdariffa  was active against all test orga-
nisms, with the highest activity against P.  aeruginosa
at a concentration of 200 g. The combination of the
three extracts had antimicrobial activity against all
test organisms, with the highest activity against P.
aerugenosa at a maximum concentration of 200 g.
The control drug, streptomycin, showed dose-dependent
antimicrobial activity against all test organisms except
P. aeruginosa.  At lower streptomycin concentrations
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Table 2
Antibacterial activity of Hibiscus sabdariffa and Zingiber ofﬁcinale extract combinations and streptomycin.
Extract Test organism Concentration of extract (mg/ml)
25 50 100 200
(Diameter of zone of inhibition (mm))
Zingiber ofﬁcinale
S. aureus 6.5 7.2 13.0 13.5
K. pneumonia – – – –
P. aeruginosa 13.0 13.5 14.0 15.5
E. coli – – – –
Hibiscus sabdariffa
S. aureus 8.0 12.0 13.0 13.5
K. pneumonia 10.5 12.5 14.0 14.0
P. aeruginosa 9.0 11.0 12.5 17.0
E. coli 8.5 9.0 12.0 13.5
Combination
S. aureus 5.6 7.5 8.3 9.2
K. pneumonia 4.5 5.1 6.6 7.3
P. aeruginosa 7.5 9.0 10.8 12.8
E. coli 4.8 5.0 6.0 6.5
Streptomycin
S. aureus 9.8 11.5 16.0 19.5
K. pneumonia – – 16.0 18.5
P. aeruginosa – – – –
E. coli 10.5 
–, no noticeable inhibition.
(25 and 50 mg/ml), no inhibitory activity was observed
against K.  pneumonia.
Table 3 shows significant increases in the body weight
of rats given extracts of A. sativum  or Z. ofﬁcinale  and
in controls, whereas rats given H. sabdariffa  extract
and those given the combination of extracts had lower
weights than controls. The organ-to-body weight ratios
of the treated rats are presented in Table 4. No signifi-
cant difference was found among the treatment groups
relative to the control, except that the heart, liver and
kidney to body ratios were higher in rats that received Z.
ofﬁcinale.
Administration of aqueous extracts of all three plants
significantly increased (p  < 0.05) the activity of AST in
serum when compared with controls (Table 5), espe-
cially by Z.  ofﬁcinale  (23.66 U/I) and by the combination
(29.00 U/I) of extracts. The highest AST activities in
liver, kidney and heart were seen with the combina-
tion (135 U/I), A.  sativum  (118.33 U/I) and Z.  ofﬁcinale
(136.67 U/I) extracts. A.  sativum  extracts also increased
the serum ALT relative to the control and the other
treatment groups (Table 6). Liver ALT activity was
increased after administration of A.  sativum  and Z.
ofﬁcinale extracts. In contrast, the activity of ALT in
rat heart and kidney was lowered in all test groups
after extract administration. The A.  sativum  extracts
caused a significant reduction in ALP activity in serum
(151.57 U/I), heart (34.96 U/I), kidney (38.64 U/I) and
liver (55.20 U/I) (Table 7). Serum ALP was significantly10.5 11.5 17.0
reduced with H.  sabdariffa  (92.69 U/I) and Z.  ofﬁcinale
(92.00 U/I).
4.  Discussion
Phytochemical analysis of the aqueous extracts of
A. sativum, H.  sabdariffa  and Z.  ofﬁcinale  revealed the
presence of flavonoids, terpenoids, alkaloids, tannins,
saponins, anthraquinones and phenolics. Other inves-
tigators have reported that extracts of H.  sabdariffa
contained a number of bioflavonoids, including phlo-
batanins, terpenoids, anthraquinones, tannins, steroids
and phenolics [46,47]. Our phytochemical findings are
also consistent with previous reports [8,9,48].
Extracts of the three plants and the combination of
extracts had potent antimicrobial activity against the test
organisms, thus corroborating previous investigations
[36,49]. Z.  ofﬁcinale  extracts have been reported to have
antifungal and antibacterial activity in  vitro  [19,25] and
to be effective in combating post-operative nausea and
vomiting [34]. Our results agree with previous reports
[2,49–54], in which the antimicrobial activity of Z.  ofﬁc-
inale was attributed to the presence of specific chemical
constituents. Extracts of H. sabdariffa  showed remark-
able activity against all the test organisms, with the
highest activity against P. aerugenosa  (17.0 mm zone)
at 200 mg/ml, thereby supporting the findings of Tseng
et al. [55] and Walker et al. [56]. In previous studies, the
least activity was found with S. aureus  (8.0 mm zone),
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Table 3
Average weight (g) of rats treated with extracts of Hibiscus sabdariffa, Zingiber ofﬁcinale and Allium sativum.
Week Control H. sabdariffa Z. ofﬁcinale A. sativum Combination
0 160.0 ± 24.1 196.7 ± 16.0*,£ 106.7 ± 11.0*,£ 166.7 ± 27.0*,£ 139.3 ± 13.9*,£
1 163.0 ± 24.2 189.0 ± 20.0*,£ 116.7 ± 15.0*,£ 179.3 ± 30.0*,£ 134.7 ± 13.8*,£
2 166.7 ± 23.7 185.3 ± 19.0*,£ 114.0 ± 11.0*,£ 172.7 ± 24.0*,£ 130.3 ± 13.4*,£
3 168.7 ± 24.4 179.3 ± 19.0*,£ 117.7 ± 11.0*,£ 175.3 ± 26.0*,£ 128.3 ± 13.4*,£
4 167.7 ± 21.4 177.0 ± 18.0*,£ 119.3 ± 10.0*,£ 175.0 ± 24.0*,£ 126.0 ± 13.1*,£
5 167.3 ± 20.6 180.7 ± 13.0*,£ 120.0 ± 10.0*,£ 172.7 ± 23.0*,£ 123.7 ± 13.2*,£
Values are mean ± SEM (n = 3).
* Significantly different at p < 0.01 relative to control.
£ Significantly different relative to the combination treatment at p < 0.001.
Table 4
Organ-to-body weight ratio of rats treated with extracts of Hibiscus sabdariffa, Zingiber ofﬁcinale and Allium sativum.
Organ Control H. sabdariffa Z. ofﬁcinale A. sativum Combination
Heart 0.31 ± 0.01 0.32 ± 0.02 0.42 ± 0.04 0.31 ± 0.04 0.38 ± 0.03
Liver 0.61 ± 0.07 0.56 ± 0.04 0.84 ± 0.08 0.60 ± 0.08 0.83 ± 0.08
Kidney 0.59 ± 0.06 0.56 ± 0.04 0.77 ± 0.12 0.56 ± 0.59 0.74 ± 0.05
Values are means ± SEM (n = 3).
Table 5
Aspartate transaminase activity in rat serum and tissues after administration of extracts of Hibiscus sabdariffa, Zingiber ofﬁcinale and Allium sativum.
Source Control H. sabdariffa Z. ofﬁcinale A. sativum Combination
Serum 16.33 ± 5.89a 18.00 ± 2.08a,b 23.66 ± 2.90c 14.66 ± 4.40b 29.00 ± 3.05d
Heart 40.66 ± 24.5a 103.33 ± 50.3b 136.67 ± 29.2d 129.67 ± 34.1c 132.00 ± 50.83d
Kidney 91.33 ± 11.9c 86.00 ± 11.93b 148.67 ± 24.6c 118.33 ± 68.5d 64.67 ± 52.54a
Liver 69.67 ± 11.5a 132.67 ± 17.1c 167.00 ± 27.1d 90.33 ± 23.32b 135.00 ± 45.0c
Values are means ± SEM (n = 3). Values with different superscripts across the same row are significantly different at p < 0.05.
Table 6
Alanine transaminase activity in rat serum and tissues after administration of extracts of Hibiscus sabdariffa, Zingiber ofﬁcinale and Allium sativum.
Source Control H. sabdariffa Z. ofﬁcinale A. sativum Combination
Serum 12.00 ± 0.58b 9.67 ± 0.67a 10.33 ± 3.92a,b 14.33 ± 2.40c 11.67 ± 0.91b
Heart 91.67 ± 1.45d 84.00 ± 6.08c 76.33 ± 11.79b 68.67 ± 10.17a 81.33 ± 10.27c
Kidney 79.33 ± 2.40b 72.00 ± 14.11a 73.33 ± 10.39a 78.00 ± 8.39b 79.00 ± 5.29b
Liver 82.00 ± 5.56a 83.00 ± 5.56a 85.67 ± 4.91b 93.67 ± 0.33c 81.67 ± 10.39a
Values are means ± SEM (n = 3). Values with different superscripts across the same row are significantly different at p < 0.05.
Table 7
Alkaline phosphatase activity in rat serum and tissues after administration of extracts of Hibiscus sabdariffa, Zingiber ofﬁcinale and Allium sativum.
Source Control H. sabdariffa Z. ofﬁcinale A. sativum Combination
Serum 497.72 ± 43.27b 92.69 ± 4.48a 92.00 ± 23.30a 151.57 ± 2.97a 526.67 ± 32.24c
Heart 782.00 ± 53.96a 816.96 ± 89.63a,b 720.36 ± 89.48a,b 34.96 ± 0.92b 554.76 ± 24.11b
Kidney 709.32 ± 53.97a 689.08 ± 45.36b 785.68 ± 46.29b 38.64 ± 6.95b 633.88 ± 39.81b
Liver 753.48 ± 18.24a 732.32 ± 40.81b 648.60 ± 08.24b 55.20 ± 6.94b 687.24 ± 26.08b
Values are means ± SEM (n = 3). Values with different superscripts across the same row are significantly different at p < 0.05.
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the highest concentration of which (200 mg/ml) yielded a
13.5-mm zone of inhibition [57]. The Z.  ofﬁcinale  extract
was active against P. aerugenosa  and S. aureus  [57,58],
with the highest activity against P. aeruginosa  (15.5 mm
zone) at 200 mg/ml [56,59]. The combination of extracts
showed the highest inhibition against P. aerugenosa
(12.8 mm zone) and the least inhibition against K. pneu-
monia (4.5 mm zone) [60,61]. The antibacterial activities
of Z.  ofﬁcinale  and H. sabdariffa  against P. aeruginosa
were better than that of the control drug, streptomycin.
The marker enzymes AST, ALT and ALP were
selected because of their relevance in assessing the
integrity of tissues in cases of disease or toxicity
consequent to drug or compound assault [62,63]. Admin-
istration of the aqueous extracts either individually or
in combination altered the relative weights of the heart,
liver and kidney of the animals when compared with
controls, which may be an indication of a toxic effect
[64]. Administration of the extracts individually or in
combination significantly altered serum and tissue AST
relative to the control, as reported previously [65]. Incon-
sistent alterations in serum and tissue ALT and ALP
activity were found. The elevated ALP activity seen after
administration of the combination of extracts might pre-
dict liver cholestasis. The alterations in AST and ALT
activity might reflect a response or adaptation of tissues
to the stress imposed by administration of the extracts.
Previous studies have shown that drugs or extracts can
promote a stressful environment in tissues or cells and
thereby lower or raise enzyme activity as part of an adap-
tation mechanism [62,66]. Several studies have shown
that H.  sabdariffa  can increase serum AST and ALP
activity [67–73]. The reductions in the activities of AST,
ALT and ALP consequent to exposure to individual or
combined extracts may also be due to inactivation of the
enzyme proteins by compounds present in the extracts
or their metabolites. Drugs or compounds can react with
enzymes, causing activation or inactivation [63].
5.  Conclusion
We present further evidence of the antimicrobial prop-
erties of crude extracts of H.  sabdariffa  and Z.  ofﬁcinale;
however, A.  sativum  had little or no antimicrobial activ-
ity. H.  sabdariffa  and  Z.  ofﬁcinale  were more effective
against P. aeruginosa  than streptomycin, which rein-
forces the scientific basis for their inclusion in traditional
medicine systems. Extracts of H.  sabdariffa,  Z.  ofﬁcinale
and A.  sativum, however, appear to have toxic poten-
tial, with a demonstrated capability to alter biochemical
indices in vital tissues. Thus, caution is required in using
unrefined extracts of these herbs in traditional settings.
[
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